Search results
BioAtla receives FDA fast track designation for ozuriftamab vedotin
Pharmaceutical Technology· 2 days agoOzuriftamab vedotin is one of several antibody therapies being developed through the company’s...
Ozuriftamab vedotin is one of several antibody therapies being developed through the company’s...